Related Experiment Video
Updated: Jul 20, 2026
A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia
Published on: February 3, 2023
Biliary atresia--translational research on key molecular processes regulating biliary injury and obstruction
1Gastroenterology, Hepatology, and Nutrition of Cincinnati Children's Hospital Medical Center, OH 45229, USA. jorge.bezerra@cchmc.org
Insights
Biliary atresia, a liver disease in infants, involves bile duct obstruction. Research identified key inflammatory molecules and showed interferon-gamma (IFNγ) plays a critical role in this obstruction, paving the way for new therapies.
Area of Science:
- Pediatric Gastroenterology and Hepatology
- Immunology
- Molecular Biology
Background:
- Biliary atresia is the leading cause of infant jaundice, characterized by bile duct inflammation and obstruction.
- Its pathogenesis is complex, but recent studies are uncovering molecular pathways involved in biliary injury.
- Understanding these pathways is crucial for developing effective treatments.
Purpose of the Study:
- To identify molecular signatures associated with biliary atresia in human patients.
- To validate findings using a mouse model of rotavirus-induced biliary atresia.
- To elucidate the role of specific cytokines, like interferon-gamma (IFNγ), in disease pathogenesis.
Main Methods:
- Genomic analysis and immunostaining of liver samples from children with biliary atresia.
- Comparative analysis of anatomical and inflammatory profiles in a mouse model.
- Mechanistic studies in mice to determine the function of IFNγ in biliary obstruction.
Main Results:
- Discovery of unique molecular signatures, particularly proinflammatory cytokines, in human biliary atresia.
- Mouse model demonstrated striking similarities to human disease profiles.
- Interferon-gamma (IFNγ) was identified as a key regulator of lymphocyte trafficking and a critical factor in inflammatory bile duct obstruction.
Conclusions:
- Combining human data with a relevant animal model advances understanding of biliary atresia.
- Interferon-gamma (IFNγ) is a critical mediator in the inflammatory process of biliary atresia.
- This research opens avenues for novel therapeutic strategies to improve outcomes for children with biliary atresia.
Abstract:
Biliary atresia is the most common cause of pathologic jaundice in young infants and results from the obstruction of the extrahepatic bile ducts by an inflammatory and fibro-obliterative process. Although the pathogenesis of the disease is multifactorial, recent patient- and animal-based studies began deciphering the molecular pathways involved in biliary injury and duct obstruction. Using large-scale genomics and immunostaining of livers from children with biliary atresia, investigators have discovered unique molecular signatures of dominant proinflammatory cytokines at the time of diagnosis. To study hypotheses generated from these patient-based studies, the anatomical and inflammatory profiles of a mouse model of rotavirus-induced biliary atresia were analyzed and found to share striking similarities with the human profiles. Then, using these mice in mechanistic studies, interferon-gamma (IFNgamma) has been shown to regulate the biliary tropism of lymphocytes to the biliary system, and to play a critical role in the inflammatory obstruction of extrahepatic bile ducts. The ability to combine human studies with a laboratory model of neonatal biliary injury and obstruction opens a new era of opportunities to advance the field of biliary atresia, and to develop new therapeutic strategies to improve long-term outcome with the native liver of children with biliary atresia.
